Narinder Pal Bhalla
Chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO) since January 2026
Narinder Pal Bhalla has filed 4 insider reports with the SEC since February 2026, as chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO). In the last 12 months Narinder Pal Bhalla sold $98.6K of stock on the open market. The latest filing, on September 28, 2026, reports grant or award at Lexeo Therapeutics, Inc. (LXEO).
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- $98.6K
Companies where Narinder Pal Bhalla is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officersince January 2026 | 84,908 | $98.6K | $2.96 | Sep 28, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 24, 2026LXEOChief Medical Officer Bhalla Narinder Pal was granted 2,714 shares, increasing direct ownership by 3% to 84,908 unitsForm 4Grant or award
- Jul 1, 2026-$98.6KLXEOChief Medical Officer Bhalla Narinder Pal was granted 55,000 shares and sold $98,593 worth of shares (22,306 units at $4.42), increasing direct ownership by 66% to 82,194 units to cover withholding taxForm 4Grant or awardOpen-market sale
- Feb 13, 2026LXEOChief Medical Officer Bhalla Narinder Pal was granted 49,500 sharesForm 4Grant or award
- Jan 20, 2026LXEONarinder Pal Bhalla became an insiderForm 3New insider
Compare Narinder Pal Bhalla with
- Narinder Pal Bhalla vs Louis Edward Tamayo1 shared
- Narinder Pal Bhalla vs Jose Manuel Otero1 shared
- Narinder Pal Bhalla vs Richard Nolan Townsend1 shared
- Narinder Pal Bhalla vs Tobin Schilke1 shared
- Narinder Pal Bhalla vs Steven Altschuler1 shared
- Narinder Pal Bhalla vs Mette Kirstine Agger1 shared
Other insiders at the same companies
- Jose Manuel OteroLXEO
- Louis Edward TamayoLXEO
- Richard Nolan TownsendLXEO
- Tobin SchilkeLXEO
- Steven AltschulerLXEO
- Mette Kirstine AggerLXEO
- Brenda CooperstoneLXEO
- Reinaldo M DiazLXEO
- Tolga TangulerLXEO
- Timothy Van HauwermeirenLXEO
- Paula H CholmondeleyLXEO
- Laura Sepp-LorenzinoLXEO
- Jenny RobertsonLXEO
- Eric AdlerLXEO
- Tai Sandi SeeLXEO
- Kyle RasbachLXEO
Questions about Narinder Pal Bhalla
- What is Narinder Pal Bhalla's role at Lexeo Therapeutics, Inc.?
- Narinder Pal Bhalla reports to the SEC as chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO), according to the latest filing on September 28, 2026.
- How many shares does Narinder Pal Bhalla own?
- After the latest filing that states it, Narinder Pal Bhalla directly owned 84,908 shares of Lexeo Therapeutics, Inc. (LXEO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Narinder Pal Bhalla bought or sold stock recently?
- The most recent open-market sale was on July 1, 2026: sold 22,306 shares of Lexeo Therapeutics, Inc. (LXEO) for $98.6K at an average of $4.42.
- How do I get alerts when Narinder Pal Bhalla files?
- Follow Narinder Pal Bhalla on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Narinder Pal Bhalla filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Narinder Pal Bhalla (SEC CIK 0002109299). Totals count each trade once, skipping amendments whose original is on file, from Feb 5, 2026 on. View on SEC EDGAR · Get this as JSON